DX2X 📈 Xtrackers - Stoxx Europe - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: LU0328475792 • Europe Large-Cap Blend Equity
DX2X: European, Stocks, Shares
The aim is for the investment to reflect the performance of the STOXX { {®}} Europe 600 Index (Index) which is designed to reflect the performance of shares of 600 companies across 18 European countries. The Index contains shares of large, medium and small companies, based on the combined value of a company's readily available shares compared to other companies. A company's weighting in the Index depends on its relative size but cannot exceed 20% of the Index at each quarterly review. The Index composition is reviewed at least quarterly. The Index is calculated on a total return net basis which means that all dividends and distributions by the companies are reinvested in the shares after tax. To achieve the aim, the Fund will attempt to replicate the Index by buying a substantial number of the shares in the Index in the same proportion as the Index as determined by the Sub-Portfolio Manager of the Fund which is Deutsche Asset Management (UK) Limited. ‣ Company URL: http://www.dws.lu ‣ Domicile: Luxembourg ‣ Index Name: Morningstar DM Eur TME NR EUR
Additional Sources for DX2X ETF
DX2X ETF Overview
Market Cap in USD | 1,666m |
Category | Europe Large-Cap Blend Equity |
TER | 0.21% |
IPO / Inception | 2009-01-20 |
DX2X ETF Ratings
Growth 5y | 56.4% |
Fundamental | - |
Dividend | 3.0% |
Rel. Strength Industry | 159 |
Analysts | - |
Fair Price Momentum | 114.91 EUR |
Fair Price DCF | - |
DX2X Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 10.0% |
DX2X Growth Ratios
Growth Correlation 3m | -48.1% |
Growth Correlation 12m | 68.3% |
Growth Correlation 5y | 88.6% |
CAGR 5y | 6.33% |
CAGR/Mean DD 5y | 1.01 |
Sharpe Ratio 12m | 0.45 |
Alpha | -10.68 |
Beta | 0.65 |
Volatility | 15.59% |
Current Volume | 17.6k |
Average Volume 20d | 19.8k |
What is the price of DX2X stocks?
As of December 27, 2024, the stock is trading at EUR 124.48 with a total of 17,621 shares traded.
Over the past week, the price has changed by -0.75%, over one month by -0.64%, over three months by -4.11% and over the past year by +7.83%.
As of December 27, 2024, the stock is trading at EUR 124.48 with a total of 17,621 shares traded.
Over the past week, the price has changed by -0.75%, over one month by -0.64%, over three months by -4.11% and over the past year by +7.83%.
Is Xtrackers - Stoxx Europe a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Xtrackers - Stoxx Europe (XETRA:DX2X) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.39 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DX2X as of December 2024 is 114.91. This means that DX2X is currently overvalued and has a potential downside of -7.69%.
Partly, yes. Based on ValueRay Analyses, Xtrackers - Stoxx Europe (XETRA:DX2X) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.39 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DX2X as of December 2024 is 114.91. This means that DX2X is currently overvalued and has a potential downside of -7.69%.
Is DX2X a buy, sell or hold?
Xtrackers - Stoxx Europe has no consensus analysts rating.
Xtrackers - Stoxx Europe has no consensus analysts rating.
What are the forecast for DX2X stock price target?
According to ValueRays Forecast Model, DX2X Xtrackers - Stoxx Europe will be worth about 126.4 in December 2025. The stock is currently trading at 124.48. This means that the stock has a potential upside of +1.53%.
According to ValueRays Forecast Model, DX2X Xtrackers - Stoxx Europe will be worth about 126.4 in December 2025. The stock is currently trading at 124.48. This means that the stock has a potential upside of +1.53%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 126.4 | 1.5% |